Retour

INVENTIVA (EPA:IVA) Inventiva announces participation at several investors conferences in May and June 2022

Directive transparence : information réglementée

23/05/2022 22:00

28/11/2022 22:00

Inventiva secures a new patent expanding the IP protection of its lead...

21/11/2022 22:00

Inventiva announces a new Director of the Board of Directors

10/11/2022 22:00

Inventiva reports 2022 Third Quarter Financial Information¹

31/10/2022 08:00

Inventiva provides an update on the development of cedirogant by AbbVie

21/10/2022 22:00

Inventiva announces a scientific presentation at the AASLD The Liver...

21/09/2022 22:40

Inventiva and Sino Biopharm announce licensing and collaboration agreement...

07/09/2022 22:00

Inventiva announces the schedule of publication and presentation of its...

28/07/2022 22:00

Inventiva Reports 2022 First-Half Financial Information¹

07/07/2022 22:00

Inventiva announces the screening of the first patient in LEGEND, a Phase...

16/06/2022 22:00

Inventiva to host a webcast with Key Opinion Leaders following the EASL...

Voir tous les communiqués de INVENTIVA